Eikon Therapeutics · 2 days ago
Senior Director, Clinical Research - Oncology
Millbrae, CA
Full-time
Onsite
Lead/Staff, Director/Executive
$270K/yr - $294K/yr
5+ years expEikon Therapeutics is a new biopharmaceutical company employing revolutionary technology to discover novel treatments for life-threatening diseases. They are seeking a seasoned physician to join their Clinical Development team as a Senior Director, Clinical Research in Oncology, where the individual will provide medical expertise and operational oversight for multiple clinical studies.
BiotechnologyHealth CareLife ScienceMedical
Responsibilities
Design and conduct early-stage or late-stage clinical development trials, including, but not limited to: assessing clinical safety and efficacy data, performing medical monitoring, and be responsible for other study-related clinical activities
Work closely with biomarker, discovery, and translational research scientists
Interpret reports, prepare oral and written results of product research, and participate in the discussion of strategies formulated within the disease areas that Eikon is focusing on
Collaborate closely with Clinical Science and other relevant functions within Eikon and potential partners including discovery, translational, and biomarker research scientists, toxicologists, clinical pharmacologists, drug safety specialists, regulatory representatives, as well as personnel from Global Clinical Operations, and other support functions
Establish strong working relationships and collaborations with external study investigators, key opinion leaders in drug development, and external alliance partners
Work closely with functional partners (Data Management, Clinical Operations, Biostatistics, Regulatory) to ensure an integrated and strategic approach to flawless execution and systematic oversight of study protocol(s) in clinical development in close collaboration with key functional stakeholders
Work in partnership with colleague study responsible physicians and clinical scientists to ensure development of high-quality study protocols including use of consistent processes/standards across studies
Work closely with functional partners to address protocol questions from Health Authorities and Ethics Committees in a consistent fashion
Qualification
Required
MD or DO degree with significant experience in Oncology
Minimum of 5-7 years of clinical experience, including 3+ years in drug development
Significant experience in clinical practice with direct patient care (preferably in Oncology)
Proven track record in leading clinical trials, including medical monitoring of early and late clinical trials and managing complex projects
In-depth knowledge of clinical research methodologies, GCP, and regulatory requirements
Ability to work effectively in a matrixed environment
Strong analytical, organizational, and problem-solving skills
Excellent communication and interpersonal skills, with the ability to collaborate effectively with cross-functional teams and external partners
Passion for innovation and improving patient outcomes
Preferred
Experience with IND and/or NDA filings
Benefits
401k plan with company matching
Medical (premiums covered by Eikon at 95%), dental and vision insurance (premiums covered by Eikon at 100%)
Mental health and wellness benefits
Weeklong summer and winter holiday shutdowns
Generous paid time off and holiday policies
Life/AD&D Insurance (premiums covered by Eikon at 100%) and optional supplemental employee-paid life/AD&D policies
Enhanced parental leave benefit
Daily subsidized lunch program when on-site
Company
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
201-500 employees
H1B Sponsorship
Eikon Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (17)
2023 (7)
2022 (3)
2021 (1)
Funding
Current Stage
Late StageTotal Funding
$1.12BKey Investors
The Column Group
2025-02-26Series D· $350.7M
2023-06-01Series C· $106M
2022-01-06Series B· $518M
Leadership Team
Roger Perlmutter
Chairman, President, and CEO
Michael Klobuchar
Chief Operating Officer
Recent News
Renaissance Capital
2026-01-11
Renaissance Capital
2026-01-11
General Catalyst
2025-12-26
Company data provided by crunchbase